2-Methoxy-5-(4-((2-(piperidin-1-yl)ethyl)amino)quinazolin-6-yl)benzamide

ID: ALA4483535

PubChem CID: 155540773

Max Phase: Preclinical

Molecular Formula: C23H27N5O2

Molecular Weight: 405.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccc3ncnc(NCCN4CCCCC4)c3c2)cc1C(N)=O

Standard InChI:  InChI=1S/C23H27N5O2/c1-30-21-8-6-17(14-19(21)22(24)29)16-5-7-20-18(13-16)23(27-15-26-20)25-9-12-28-10-3-2-4-11-28/h5-8,13-15H,2-4,9-12H2,1H3,(H2,24,29)(H,25,26,27)

Standard InChI Key:  RYATVBKGMRPDSJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    5.4424   -4.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4413   -5.3842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1493   -5.7932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1475   -4.1558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8561   -4.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8569   -5.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5654   -5.7872    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2737   -5.3763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2690   -4.5542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5598   -4.1508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7367   -4.1564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7378   -3.3381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0308   -2.9298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3222   -3.3386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3251   -4.1600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0326   -4.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6139   -2.9311    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6126   -2.1139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5555   -3.3337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2610   -2.9213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9643   -3.3265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6717   -2.9173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3793   -3.3293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0846   -2.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0881   -2.1060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3801   -1.6959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6687   -2.1033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6189   -4.5713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9097   -4.1653    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6220   -5.3885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  1 11  1  0
 14 17  1  0
 17 18  1  0
 10 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 15 28  1  0
 28 29  1  0
 28 30  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4483535

    ---

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2165AlogP: 3.30#Rotatable Bonds: 7
Polar Surface Area: 93.37Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.71CX Basic pKa: 8.76CX LogP: 2.70CX LogD: 1.32
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: -1.14

References

1. Hei YY, Xin M, Zhang H, Xie XX, Mao S, Zhang SQ..  (2016)  Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors.,  26  (18): [PMID:27544401] [10.1016/j.bmcl.2016.08.015]

Source